Company Brainstorm Cell Therapeutics Inc.
Equities
BCLI
US10501E2019
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5345 USD | +0.47% | +0.47% | +95.79% |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 | CI |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Management Changes | CI |
Business Summary
Number of employees: 29
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chaim Lebovits
CEO | Chief Executive Officer | 53 | 07-06-30 |
Alla Patlis
DFI | Director of Finance/CFO | 37 | 12-12-22 |
Chief Tech/Sci/R&D Officer | - | 22-05-11 | |
Bob Dagher
CTO | Chief Tech/Sci/R&D Officer | 55 | 23-07-16 |
Yael Gothelf
CTO | Chief Tech/Sci/R&D Officer | - | 06-12-31 |
Stacy Lindborg
BRD | Director/Board Member | 53 | 20-05-31 |
Uri Yablonka
BRD | Director/Board Member | 47 | 14-06-05 |
General Counsel | - | 22-05-11 | |
Mary Kay Turner
LAW | General Counsel | - | 17-08-06 |
Yossef Levy
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Irit Arbel
FOU | Founder | 64 | 00-09-21 |
Uri Yablonka
BRD | Director/Board Member | 47 | 14-06-05 |
Jacob Frenkel
CHM | Chairman | 81 | 20-03-29 |
Director/Board Member | 63 | 21-10-27 | |
Director/Board Member | 61 | 18-02-04 | |
Stacy Lindborg
BRD | Director/Board Member | 53 | 20-05-31 |
Nir Naor
BRD | Director/Board Member | 50 | 23-06-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 68,341,857 | 59,284,308 ( 86.75 %) | 0 | 86.75 % |
Company contact information
Brainstorm Cell Therapeutics, Inc.
1325 Avenue of Americas 28th floor
10019, New York
+201 488 0460
http://www.brainstorm-cell.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+95.79% | 36.53M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- BCLI Stock
- Company Brainstorm Cell Therapeutics Inc.